148 related articles for article (PubMed ID: 36812120)
1. Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.
Mungle T; Das N; Pal S; Gogoi MP; Das P; Ghara N; Ghosh D; Arora RS; Bhakta N; Saha V; Krishnan S
Cancer Med; 2023 Feb; 12(3):3499-3508. PubMed ID: 36812120
[TBL] [Abstract][Full Text] [Related]
2. Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
Li XY; Li JQ; Luo XQ; Wu XD; Sun X; Xu HG; Li CG; Liu RY; Sun XF; Chen HQ; Lin YD; Li CK; Fang JP
BMC Cancer; 2021 Jan; 21(1):59. PubMed ID: 33435902
[TBL] [Abstract][Full Text] [Related]
3. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the present and previously used protocol of risk stratification in children with acute lymphoblastic leukemia].
Glodkowska E; Bialas A; Jackowska T
Med Wieku Rozwoj; 2007; 11(2 Pt 1):153-8. PubMed ID: 17625285
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
[TBL] [Abstract][Full Text] [Related]
7. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
[TBL] [Abstract][Full Text] [Related]
8. Outcome of treatment with a low cost protocol in adults with T cell acute lymphoblastic leukemia in a tertiary care center in India.
Abraham A; George B; Ahmed R; Viswabandya A; Mathews V; Lakshmi KM; Srivastava VM; Chandy M; Srivastava A
Leuk Lymphoma; 2014 Apr; 55(4):947-9. PubMed ID: 23772647
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: the influence of new medication and diagnostic technology.
van Litsenburg RR; Uyl-de Groot CA; Raat H; Kaspers GJ; Gemke RJ
Pediatr Blood Cancer; 2011 Dec; 57(6):1005-10. PubMed ID: 21618420
[TBL] [Abstract][Full Text] [Related]
10. Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country.
Sutaryo S; Widjajanto PH; Mulatsih S; Ardianto B; Pangarso AWS; Supriyadi E; Purwanto I; Adelin CP; Lestari RP; Sagoro L; Christian SD; Sabrina DS; Verena N; Kors WA; Kaspers GJL; Veerman AJP
Pediatr Blood Cancer; 2022 Nov; 69(11):e29875. PubMed ID: 35856702
[TBL] [Abstract][Full Text] [Related]
11. Hospitalization rate and costs in acute lymphoblastic leukemia of childhood in a low-income group: Financial impact in Northeast Mexico.
Jaime-Pérez JC; Fernández LT; Jiménez-Castillo RA; Colunga-Pedraza JE; Padilla-Medina JR; Mancías-Guerra C; Gómez-Almaguer D
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598592
[TBL] [Abstract][Full Text] [Related]
12. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
[No Abstract] [Full Text] [Related]
13. Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada.
Gupta S; Sutradhar R; Li Q; Athale U; Bassal M; Breakey V; Gibson PJ; Patel S; Silva M; Zabih V; Pechlivanoglou P; Pole JD; Mittmann N
Eur J Cancer; 2021 Jul; 151():126-135. PubMed ID: 33979728
[TBL] [Abstract][Full Text] [Related]
14. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
[TBL] [Abstract][Full Text] [Related]
15. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
[No Abstract] [Full Text] [Related]
16. Treatment of childhood acute lymphoblastic leukemia with protocol TCL-842 in Taiwan: the Taiwan Children's Cancer Study Group.
Yang CP; Lin ST; Liang DC; Hung IJ; Yang YM; Chen HN; Hsieh YL; Law KL; Lin MT; Twu BH
J Formos Med Assoc; 1993 May; 92(5):431-9. PubMed ID: 8104596
[TBL] [Abstract][Full Text] [Related]
17. The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China.
Luo XQ; Ke ZY; Guan XQ; Zhang YC; Huang LB; Zhu J
Pediatr Blood Cancer; 2008 Aug; 51(2):204-9. PubMed ID: 18454471
[TBL] [Abstract][Full Text] [Related]
18. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of pediatric acute lymphoblastic leukemia in Yeungnam region: Multicenter retrospective study of Study Alliance of Yeungnam Pediatric Hematology-Oncology (SAYPH).
Yang EJ; Park KM; Lee JM; Hah JO; Park SK; Suh JK; Kim JY; Lee KS; Park J; Park ES; Lim J; Shim YJ; Kim HS; Kong SG; Chueh H; Choi EJ; Park JA; Lim YT
Pediatr Hematol Oncol; 2018 May; 35(4):276-287. PubMed ID: 30633619
[TBL] [Abstract][Full Text] [Related]
20. Adult Acute Lymphoblastic Leukemia: Limitations of Intensification of Therapy in a Developing Country.
Jain P; Korula A; Deshpande P; Pn N; Abu Alex A; Abraham A; Srivastava A; Janet NB; Lakshmi KM; Balasubramanian P; George B; Mathews V
J Glob Oncol; 2018 Sep; 4():1-12. PubMed ID: 30222028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
